Navigation Links
ConjuGon raises $3.3 million to fund clinical trials

Madison, Wis.- ConjuGon, Inc., a privately-held biopharmaceutical company, has raised $3.3 million in an investment round led by Rosetta Partners, a private investment firm based in Lake Forest, Ill.

The Madison-based ConjuGon will use the capital for clinical trials of its treatment for the infections of large wounds, and to fund the developme......

Full article >>> ">Centocor.

Alicia Loffler, director of the Kellogg Center for Biotechnology at Northwestern University.

Tom Rolfs, a member of the Wisconsin Investment Partners and a partner of Red Top Capital.

Carl Spalding, pas......

Full article >>>
'"/>

Source:wistechnology.com By WTN 12/13/06


Related biology technology :

1. ConjuGon gets $730K to treat infections
2. ConjuGon lands $1 million angel investment
3. ConjuGon receives $500,000 to battle bacteria
4. ConjuGon to present at Sachs-Bloomberg Global Biotech Forum
5. ConjuGon Awarded $250,000
6. TomoTherapy raises $223 million in IPO
7. Fusion 2007: CA chief says IT complexity raises risk
8. Inline intellectual property raises legal issues
9. Biotech with Madison ties raises $21M in capital
10. Nerites raises $1 million to improve medical tech
11. Brady Corp. raises $137 million in public offering
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... , ... January 11, 2017 , ... ... scientific grants to ground-breaking microbiome studies. Its most recent microbiome impact grant award ... who will study the effect of long-term use of oral antibiotics, prescribed for ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... make all the difference when navigating the challenges young businesses face. With the ... the extensive expertise and experience of Geoff DiMasi, Founder and Principal of interactive ...
(Date:1/11/2017)... ... January 11, 2017 , ... Back pain relief technology is now available ... Surgery for positive back pain relief for WAR members. , This spinal restoration platform ... be life changing for millions suffering from chronic back pain. , What A ...
(Date:1/11/2017)... and BENGALURU, India , Jan. ... Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced ... accepted Mylan,s biologics license application (BLA) for MYL-1401O, a ... This product is a proposed biosimilar to branded trastuzumab, ... The anticipated FDA goal date set under the Biosimilar ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec 15, 2016 ... Research and Markets has announced the addition of ... The report forecasts the global military biometrics market to ... The report has been prepared based on an in-depth market analysis ... its growth prospects over the coming years. The report also includes a ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
(Date:12/8/2016)... 2016  Singulex, Inc., the leader in Next Generation ... a license and supply agreement with Thermo Fisher Scientific, ... Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a ... used to diagnose systemic bacterial infection and sepsis and ... aid in assessing the risk of critically ill patients ...
Breaking Biology News(10 mins):